(Q39712811)

14 September 2017

Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome (English)

1 reference

14 September 2017

A Mehta

1 reference

14 September 2017

A Sinha

1 reference

14 September 2017

A Sharma

1 reference

14 September 2017

R Gupta

1 reference

14 September 2017

A Gulati

1 reference

14 September 2017

P Hari

1 reference

14 September 2017

A K Dinda

1 reference

14 September 2017

A Bagga

1 reference

14 September 2017

1 January 2013

1 reference

Indian Journal of Nephrology

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

41-46

1 reference

Clinical trial of focal segmental glomerulosclerosis in children and young adults

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Experience with tacrolimus in children with steroid-resistant nephrotic syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Non-corticosteroid treatment for nephrotic syndrome in children

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Management of steroid resistant nephrotic syndrome.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621237

Treatment targets in renal fibrosis

20 August 2018

1 reference

12 December 2020

Long-term clinical and pathological effects of cyclosporin in children with nephrosis

1 reference

12 December 2020

Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies

1 reference

12 December 2020

Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies

1 reference

12 December 2020

Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis

1 reference

12 December 2020

Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

12 December 2020

Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome

1 reference

12 December 2020

Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine

1 reference

12 December 2020

One-center experience with cyclosporine in refractory nephrotic syndrome in children

1 reference

12 December 2020

Identifiers

DOI

10.4103/0971-4065.107197

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

23580804

1 reference